13 employees
Gamma Biosciences is a next-generation bioprocessing for advanced therapies by acquiring or investing in high-potential businesses.
2019
$200M
from 1 investors over 1 rounds
Gamma Biosciences raised $200M on February 19, 2020
Investors: KKR & Co. Inc.